Skip to main content
ArticleOPEN ACCESS

Genetic diversity and antimicrobial drug resistance of serotype VI group B Streptococcus, Canada

Emerging Infectious Diseases
DOI: 10.3201/eid2410.171711
2Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Two genetically dissimilar sequence type 1 clades dominate the serotype VI group B Streptococcus population of strains causing invasive disease in Canada. Isolates of this rare serotype, recovered mainly from adult patients, were all susceptible to penicillin and vancomycin. However, we observed resistance to erythromycin and clindamycin.

Cite

CITATION STYLE

APA

Neemuchwala, A., Teatero, S., Liang, L., Martin, I., Demzcuk, W., McGeer, A., & Fittipaldi, N. (2018, October 1). Genetic diversity and antimicrobial drug resistance of serotype VI group B Streptococcus, Canada. Emerging Infectious Diseases. Centers for Disease Control and Prevention (CDC). https://doi.org/10.3201/eid2410.171711

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free